Mind Medicine Inc. (NEO: MMED,OTCQB: MMEDF, DE: MMQ), a NYC-based psychedelic medicine biotech company, closed the previously announced acquisition of HealthMode, a digital medicine and therapeutics startup that uses Artificial Intelligence (AI)-enabled digital measurement to increase the precision and speed of clinical research and patient monitoring.
In consideration for the acquisition of HealthMode, MindMed has issued 81,497 multiple voting shares of MindMed (equivalent to 8,149,700 subordinate voting shares) and the payment of approximately CAD$286,000 in cash.
Read the entire press release HERE
FinSMEs
27/02/2021